{"id":8770,"date":"2022-08-11T10:24:21","date_gmt":"2022-08-11T10:24:21","guid":{"rendered":"https:\/\/ultimatehealthreport.com\/cannabis-useful-treatment-strategy-for-fibromyalgia-patients\/"},"modified":"2022-08-11T10:24:21","modified_gmt":"2022-08-11T10:24:21","slug":"cannabis-useful-treatment-strategy-for-fibromyalgia-patients","status":"publish","type":"post","link":"https:\/\/ultimatehealthreport.com\/cannabis-useful-treatment-strategy-for-fibromyalgia-patients\/","title":{"rendered":"Cannabis \u201cUseful Treatment Strategy\u201d for Fibromyalgia Patients"},"content":{"rendered":"


\n<\/p>\n

\t\t<\/p>\n

Fibromyalgia is a serious problem across the globe, affecting people of all ages. It is\u00a0estimated\u00a0that as many as one out of every twenty people on earth suffer from the condition to some degree.<\/p>\n

According to\u00a0Mayo Clinic, <\/em>\u201cFibromyalgia\u00a0is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues.\u201d<\/p>\n

Unfortunately, there is currently no known cure for fibromyalgia. However, researchers in Canada have found evidence that medical cannabis can be an effective treatment for some patients. Below is more information about it via a news release from\u00a0NORML:<\/p>\n

Montreal, Canada:\u00a0<\/strong>Cannabis products are associated with symptom relief among fibromyalgia (FM) patients, according to\u00a0data\u00a0published in the journal\u00a0Arthritis Care & Research<\/em>.<\/p>\n

Canadian researchers assessed the efficacy of medical cannabis products (flower or extracts) over a one-year period in a cohort of patients with FM. Investigators assessed patients\u2019 levels of pain intensity, sleep quality, and depression\/anxiety every three months. All of the subjects enrolled in the study were qualified to use medical cannabis products by their general practitioner.<\/p>\n

Consistent with\u00a0other studies, researchers reported an association between the consumption of medical cannabis and improvements in subjects\u2019 sleep, depression\/anxiety, and pain \u2013 with the greatest reduction in pain intensity (a mean decrease of 1.7 points on a zero to 10 scale) occurring within the first six-months of treatment.<\/p>\n

Authors reported: \u201cOur current findings are consistent with observations of pain relief, improved sleep, and alleviation of symptoms of anxiety and depression in other studies among patients with chronic pain using medical cannabis. <\/p>\n

Although preliminary, our findings suggest that improvements in negative affect and sleep might represent potential mechanisms of action underlying pain reductions among FM patients who are using medical cannabis.\u201d<\/p>\n

\n

\n